Following this reasoning, inhibition of the NLRP3 inflammasome with MCC950 could be useful in the treatment of COVID-19.
Kwa mantiki hii, uzuiaji wa NLRP3 inflammasome kwa kutumia MCC950 kunaweza kuwa muhimu katika matibabu ya COVID-19.